Source:http://linkedlifedata.com/resource/pubmed/id/12393516
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-1-31
|
pubmed:abstractText |
Fanconi anemia (FA) is an autosomal recessive disorder characterized by cellular hypersensitivity to DNA cross-linking agents and cancer predisposition. Recent evidence for the interactions of ataxia-telangiectasia mutated protein ATM and breast cancer susceptibility proteins BRCA1 and BRCA2 (identified as FANCD1) with other known FA proteins suggests that FA proteins have a significant role in DNA repair/recombination and cell cycle control. The International Fanconi Anemia Registry (IFAR), a prospectively collected database of FA patients, allows us the unique opportunity to analyze the natural history of this rare, clinically heterogeneous disorder in a large number of patients. Of the 754 subjects in this study, 601 (80%) experienced the onset of bone marrow failure (BMF), and 173 (23%) had a total of 199 neoplasms. Of these neoplasms, 120 (60%) were hematologic and 79 (40%) were nonhematologic. The risk of developing BMF and hematologic and nonhematologic neoplasms increased with advancing age with a 90%, 33%, and 28% cumulative incidence, respectively, by 40 years of age. Univariate analysis revealed a significantly earlier onset of BMF and poorer survival for complementation group C compared with groups A and G; however, there was no significant difference in the time to hematologic or nonhematologic neoplasm development between these groups. Multivariate analysis of overall survival time shows that FANCC mutations (P =.007) and hematopoietic stem cell transplantation (P = <.0001) define a poor-risk subgroup. The results of this study of patients registered in the IFAR over a 20-year period provide information that will enable better prediction of outcome and aid clinicians with decisions regarding major therapeutic modalities.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/5T32 CA09685,
http://linkedlifedata.com/resource/pubmed/grant/M01-RR00102,
http://linkedlifedata.com/resource/pubmed/grant/M01-RR06020,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA82678,
http://linkedlifedata.com/resource/pubmed/grant/R37 HL32987
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1249-56
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12393516-Bone Marrow Diseases,
pubmed-meshheading:12393516-Fanconi Anemia,
pubmed-meshheading:12393516-Female,
pubmed-meshheading:12393516-Genotype,
pubmed-meshheading:12393516-Hematologic Neoplasms,
pubmed-meshheading:12393516-Humans,
pubmed-meshheading:12393516-International Cooperation,
pubmed-meshheading:12393516-Male,
pubmed-meshheading:12393516-Mutation,
pubmed-meshheading:12393516-Neoplasms,
pubmed-meshheading:12393516-Phenotype,
pubmed-meshheading:12393516-Prognosis,
pubmed-meshheading:12393516-Registries,
pubmed-meshheading:12393516-Sex Characteristics,
pubmed-meshheading:12393516-Stem Cell Transplantation,
pubmed-meshheading:12393516-Survival Rate,
pubmed-meshheading:12393516-Time Factors
|
pubmed:year |
2003
|
pubmed:articleTitle |
A 20-year perspective on the International Fanconi Anemia Registry (IFAR).
|
pubmed:affiliation |
Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|